When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BOLD - Audentes Therapeutics to provide update on interim data from ASPIRO trial
Audentes Therapeutics Inc.
Audentes Therapeutics (NASDAQ:BOLD) will present new positive interim data from ASPIRO, the Phase 1/2 clinical trial of AT132 for the treatment of X-linked Myotubular Myopathy (XLMTM) at the 23rd International Annual Congress of the World Muscle Society, on October 5.
More news on: Audentes Therapeutics, Healthcare stocks news, Stocks on the move,